Targeted Therapy | N = 33 | Stable disease as best response | Median duration of response (months) |
---|---|---|---|
Sirolimus alone | 3 | 1 | 4,75 |
Sirolimus Cy | 13 | 7 (3 maintained complete remission) | 5,4 |
Sirolimus Cy Adriamycine | 1 | 1 | 6,2 |
Sirolimus Cy Vinorelbine | 3 | 0 | |
Sirolimus Cy Zolendronate | 1 | 1 | 9 |
Sirolimus Irinotecan | 2 | 0 | |
Sorafenib | 4 | 3 | 3,1 |
Sunitinib | 5 | 2 (1 PR) | 3,4 |
Pazopanib | 1 | 0 | |
Total | 33 | 15 | 4,8 |